Search | VHL CLAP/WR-PAHO/WHO

1.

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.

Bruna, Alejandra; Rueda, Oscar M; Greenwood, Wendy; Batra, Ankita Sati; Callari, Maurizio; Batra, Rajbir Nath; Pogrebniak, Katherine; Sandoval, Jose; Cassidy, John W; Tufegdzic-Vidakovic, Ana; Sammut, Stephen-John; Jones, Linda; Provenzano, Elena; Baird, Richard; Eirew, Peter; Hadfield, James; Eldridge, Matthew; McLaren-Douglas, Anne; Barthorpe, Andrew; Lightfoot, Howard; O'Connor, Mark J; Gray, Joe; Cortes, Javier; Baselga, Jose; Marangoni, Elisabetta; Welm, Alana L; Aparicio, Samuel; Serra, Violeta; Garnett, Mathew J; Caldas, Carlos.

Cell ; 167(1): 260-274.e22, 2016 09 22.

Article in English | MEDLINE | ID: mdl-27641504

2.

Antibody-drug conjugates: Smart chemotherapy delivery across tumor histologies.

Tarantino, Paolo; Carmagnani Pestana, Roberto; Corti, Chiara; Modi, Shanu; Bardia, Aditya; Tolaney, Sara M; Cortes, Javier; Soria, Jean-Charles; Curigliano, Giuseppe.

CA Cancer J Clin ; 72(2): 165-182, 2022 03.

Article in English | MEDLINE | ID: mdl-34767258

3.

Enhancing global access to cancer medicines.

Cortes, Javier; Perez-García, Jose Manuel; Llombart-Cussac, Antonio; Curigliano, Giuseppe; El Saghir, Nagi S; Cardoso, Fatima; Barrios, Carlos H; Wagle, Shama; Roman, Javier; Harbeck, Nadia; Eniu, Alexandru; Kaufman, Peter A; Tabernero, Josep; García-Estévez, Laura; Schmid, Peter; Arribas, Joaquín.

CA Cancer J Clin ; 70(2): 105-124, 2020 03.

Article in English | MEDLINE | ID: mdl-32068901

4.

Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.

Turner, Nicholas C; Oliveira, Mafalda; Howell, Sacha J; Dalenc, Florence; Cortes, Javier; Gomez Moreno, Henry L; Hu, Xichun; Jhaveri, Komal; Krivorotko, Petr; Loibl, Sibylle; Morales Murillo, Serafin; Okera, Meena; Park, Yeon Hee; Sohn, Joohyuk; Toi, Masakazu; Tokunaga, Eriko; Yousef, Samih; Zhukova, Lyudmila; de Bruin, Elza C; Grinsted, Lynda; Schiavon, Gaia; Foxley, Andrew; Rugo, Hope S.

N Engl J Med ; 388(22): 2058-2070, 2023 Jun 01.

Article in English | MEDLINE | ID: mdl-37256976

5.

3-year invasive disease-free survival with chemotherapy de-escalation using an ¹⁸F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.

Pérez-García, José Manuel; Cortés, Javier; Ruiz-Borrego, Manuel; Colleoni, Marco; Stradella, Agostina; Bermejo, Begoña; Dalenc, Florence; Escrivá-de-Romaní, Santiago; Calvo Martínez, Lourdes; Ribelles, Nuria; Marmé, Frederik; Cortés, Alfonso; Albacar, Cinta; Gebhart, Geraldine; Prat, Aleix; Kerrou, Khaldoun; Schmid, Peter; Braga, Sofia; Di Cosimo, Serena; Gion, Maria; Antonarelli, Gabriele; Popa, Crina; Szostak, Emilia; Alcalá-López, Daniel; Gener, Petra; Rodríguez-Morató, Jose; Mina, Leonardo; Sampayo-Cordero, Miguel; Llombart-Cussac, Antonio.

Lancet ; 403(10437): 1649-1659, 2024 Apr 27.

Article in English | MEDLINE | ID: mdl-38582092

6.

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.

Cortes, Javier; Rugo, Hope S; Cescon, David W; Im, Seock-Ah; Yusof, Mastura M; Gallardo, Carlos; Lipatov, Oleg; Barrios, Carlos H; Perez-Garcia, Jose; Iwata, Hiroji; Masuda, Norikazu; Torregroza Otero, Marco; Gokmen, Erhan; Loi, Sherene; Guo, Zifang; Zhou, Xuan; Karantza, Vassiliki; Pan, Wilbur; Schmid, Peter.

N Engl J Med ; 387(3): 217-226, 2022 07 21.

Article in English | MEDLINE | ID: mdl-35857659

7.

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.

Cortés, Javier; Kim, Sung-Bae; Chung, Wei-Pang; Im, Seock-Ah; Park, Yeon Hee; Hegg, Roberto; Kim, Min Hwan; Tseng, Ling-Ming; Petry, Vanessa; Chung, Chi-Feng; Iwata, Hiroji; Hamilton, Erika; Curigliano, Giuseppe; Xu, Binghe; Huang, Chiun-Sheng; Kim, Jee Hyun; Chiu, Joanne W Y; Pedrini, Jose Luiz; Lee, Caleb; Liu, Yali; Cathcart, Jillian; Bako, Emarjola; Verma, Sunil; Hurvitz, Sara A.

N Engl J Med ; 386(12): 1143-1154, 2022 03 24.

Article in English | MEDLINE | ID: mdl-35320644

8.

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.

Schmid, Peter; Cortes, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kümmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Fasching, Peter A; Cardoso, Fatima; Andersen, Jay; Patt, Debra; Danso, Michael; Ferreira, Marta; Mouret-Reynier, Marie-Ange; Im, Seock-Ah; Ahn, Jin-Hee; Gion, Maria; Baron-Hay, Sally; Boileau, Jean-François; Ding, Yu; Tryfonidis, Konstantinos; Aktan, Gursel; Karantza, Vassiliki; O'Shaughnessy, Joyce.

N Engl J Med ; 386(6): 556-567, 2022 02 10.

Article in English | MEDLINE | ID: mdl-35139274

9.

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations.

Meattini, Icro; Becherini, Carlotta; Caini, Saverio; Coles, Charlotte E; Cortes, Javier; Curigliano, Giuseppe; de Azambuja, Evandro; Isacke, Clare M; Harbeck, Nadia; Kaidar-Person, Orit; Marangoni, Elisabetta; Offersen, Birgitte V; Rugo, Hope S; Salvestrini, Viola; Visani, Luca; Morandi, Andrea; Lambertini, Matteo; Poortmans, Philip; Livi, Lorenzo.

Lancet Oncol ; 25(2): e73-e83, 2024 Feb.

Article in English | MEDLINE | ID: mdl-38301705

10.

Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial.

Rugo, Hope S; Bardia, Aditya; Marmé, Frederik; Cortés, Javier; Schmid, Peter; Loirat, Delphine; Trédan, Olivier; Ciruelos, Eva; Dalenc, Florence; Gómez Pardo, Patricia; Jhaveri, Komal L; Delaney, Rosemary; Valdez, Theresa; Wang, Hao; Motwani, Monica; Yoon, Oh Kyu; Verret, Wendy; Tolaney, Sara M.

Lancet ; 402(10411): 1423-1433, 2023 10 21.

Article in English | MEDLINE | ID: mdl-37633306

11.

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.

Hurvitz, Sara A; Hegg, Roberto; Chung, Wei-Pang; Im, Seock-Ah; Jacot, William; Ganju, Vinod; Chiu, Joanne Wing Yan; Xu, Binghe; Hamilton, Erika; Madhusudan, Srinivasan; Iwata, Hiroji; Altintas, Sevilay; Henning, Jan-Willem; Curigliano, Giuseppe; Perez-Garcia, José Manuel; Kim, Sung-Bae; Petry, Vanessa; Huang, Chiun-Sheng; Li, Wei; Frenel, Jean-Sebastien; Antolin, Silvia; Yeo, Winnie; Bianchini, Giampaolo; Loi, Sherene; Tsurutani, Junji; Egorov, Anton; Liu, Yali; Cathcart, Jillian; Ashfaque, Shahid; Cortés, Javier.

Lancet ; 401(10371): 105-117, 2023 01 14.

Article in English | MEDLINE | ID: mdl-36495879

12.

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Bardia, Aditya; Hurvitz, Sara A; Tolaney, Sara M; Loirat, Delphine; Punie, Kevin; Oliveira, Mafalda; Brufsky, Adam; Sardesai, Sagar D; Kalinsky, Kevin; Zelnak, Amelia B; Weaver, Robert; Traina, Tiffany; Dalenc, Florence; Aftimos, Philippe; Lynce, Filipa; Diab, Sami; Cortés, Javier; O'Shaughnessy, Joyce; Diéras, Véronique; Ferrario, Cristiano; Schmid, Peter; Carey, Lisa A; Gianni, Luca; Piccart, Martine J; Loibl, Sibylle; Goldenberg, David M; Hong, Quan; Olivo, Martin S; Itri, Loretta M; Rugo, Hope S.

N Engl J Med ; 384(16): 1529-1541, 2021 04 22.

Article in English | MEDLINE | ID: mdl-33882206

13.

Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.

Gion, María; García-Mosquera, Juan José; Pérez-García, José Manuel; Peg, Vicente; Ruiz-Borrego, Manuel; Stradella, Agostina; Bermejo, Begoña; Guerrero, José Antonio; López-Montero, Laura; Mancino, Mario; Rodríguez-Morató, José; Antonarelli, Gabriele; Sampayo-Cordero, Miguel; Llombart-Cussac, Antonio; Cortés, Javier.

Breast Cancer Res Treat ; 2024 Mar 08.

Article in English | MEDLINE | ID: mdl-38456970

14.

Clinicopathological and molecular predictors of [¹⁸F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.

Llombart-Cussac, Antonio; Prat, Aleix; Pérez-García, José Manuel; Mateos, José; Pascual, Tomás; Escrivà-de-Romani, Santiago; Stradella, Agostina; Ruiz-Borrego, Manuel; de Las Heras, Begoña Bermejo; Keyaerts, Marleen; Galvan, Patricia; Brasó-Maristany, Fara; García-Mosquera, Juan José; Guiot, Thomas; Gion, María; Sampayo-Cordero, Miguel; Di Cosimo, Serena; Pérez-Escuredo, Jhudit; de Frutos, Manuel Atienza; Cortés, Javier; Gebhart, Geraldine.

Eur J Nucl Med Mol Imaging ; 2024 Apr 08.

Article in English | MEDLINE | ID: mdl-38587643

15.

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer: a plain language summary of the DESTINY-Breast03 study.

Cortés, Javier.

Future Oncol ; 20(4): 167-178, 2024 Feb.

Article in English | MEDLINE | ID: mdl-38059424

16.

A plain language summary of the TROPiCS-02 study in patients with breast cancer (HR-positive/HER2-negative).

Rugo, Hope S; Bardia, Aditya; Marmé, Frederik; Cortés, Javier; Schmid, Peter; Spears, Patricia A; Tolaney, Sara M.

Future Oncol ; 20(11): 635-651, 2024 Apr.

Article in English | MEDLINE | ID: mdl-38270051

17.

Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer.

Franco-Mateos, Emma; Souza-Egipsy, Virginia; García-Estévez, Laura; Pérez-García, José; Gion, María; Garrigós, Laia; Cortez, Patricia; Saavedra, Cristina; Gómez, Patricia; Ortiz, Carolina; Cruz, Víctor L; Ramos, Javier; Cortés, Javier; Vega, Juan F.

Int J Mol Sci ; 25(7)2024 Apr 01.

Article in English | MEDLINE | ID: mdl-38612751

18.

XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.

Schmid, Peter; Cortes, Javier; Joaquim, Ana; Jañez, Noelia Martínez; Morales, Serafín; Díaz-Redondo, Tamara; Blau, Sibel; Neven, Patrick; Lemieux, Julie; García-Sáenz, José Ángel; Hart, Lowell; Biyukov, Tsvetan; Baktash, Navid; Massey, Dan; Burris, Howard A; Rugo, Hope S.

Breast Cancer Res ; 25(1): 67, 2023 06 12.

Article in English | MEDLINE | ID: mdl-37308971

19.

Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors.

Llinàs-Arias, Pere; Ensenyat-Mendez, Miquel; Íñiguez-Muñoz, Sandra; Orozco, Javier I J; Valdez, Betsy; Salomon, Matthew P; Matsuba, Chikako; Solivellas-Pieras, Maria; Bedoya-López, Andrés F; Sesé, Borja; Mezger, Anja; Ormestad, Mattias; Unzueta, Fernando; Strand, Siri H; Boiko, Alexander D; Hwang, E Shelley; Cortés, Javier; DiNome, Maggie L; Esteller, Manel; Lupien, Mathieu; Marzese, Diego M.

Mol Cancer ; 22(1): 190, 2023 11 28.

Article in English | MEDLINE | ID: mdl-38017545

20.

Top advances of the year: Breast cancer.

Saavedra, Cristina; Gion, María; Cortés, Javier; Llombart-Cussac, Antonio.

Cancer ; 129(12): 1791-1794, 2023 06 15.

Article in English | MEDLINE | ID: mdl-37014257

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Config filters

Your selection (0)

Export format:

Export: